Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
₹ 41.96
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very strong margins and returns
Data is available to registered users only
Data is available to registered users only
About
Shukra Pharmaceuticals Ltd. manufactures and markets pharmaceutical products in both domestic and international markets. Its portfolio includes antibiotics, macrolides, quinolones, anti bacterial, anti fungal, anti malarial, anti viral, anti protozoal, anti anthelmintic, sedative and tranquilliser, anti depressant, anti manic, anti emetic, anti ulcer, beta blockers, diuretics, analgesic, analgesic, muscle relaxants, anti tuberculosis, vitamin products, anti...
Company Valuation
From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. Specifically, the stock is 'expensive' on P/E, overvalued
Data is available to registered users only
Buy
Sell